Alamar Biosciences Inc Cl A (ALMR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | |
| Cash Flows From Operating Activities | ||
| Net Income | -29,819 | -47,073 |
| Depreciation Amortization | 3,935 | 1,383 |
| Accounts receivable | -5,910 | -4,684 |
| Accounts payable and accrued liabilities | -572 | 2,917 |
| Other Working Capital | -32,570 | -11,989 |
| Other Operating Activity | 11,328 | 4,232 |
| Operating Cash Flow | $-53,608 | $-55,214 |
| Cash Flows From Investing Activities | ||
| Change In Deposits | 52,560 | -50,545 |
| PPE Investments | -5,373 | -2,948 |
| Other Investing Activity | -1,011 | -440 |
| Investing Cash Flow | $46,176 | $-53,933 |
| Cash Flows From Financing Activities | ||
| Debt Issued | 10,000 | N/A |
| Debt Repayment | N/A | -15,000 |
| Common Stock Issued | 1,493 | 940 |
| Other Financing Activity | -657 | 127,477 |
| Financing Cash Flow | $10,836 | $113,417 |
| Exchange Rate Effect | -172 | -1 |
| Beginning Cash Position | 31,677 | 27,408 |
| End Cash Position | 34,909 | 31,677 |
| Net Cash Flow | $3,232 | $4,269 |
| Free Cash Flow | ||
| Operating Cash Flow | -53,608 | -55,214 |
| Capital Expenditure | -5,373 | -2,948 |
| Free Cash Flow | -58,981 | -58,162 |